While the first two are event driven, the unblinding (which is end of trial) is planned as a fixed event and probably only depends on timely enrolment of the 582 SUNRISE patients in the 161 world-wide centers in DEC 2015.
Not true—the final analysis is triggered by a predetermined number of deaths in the two arms combined.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”